NewAmsterdam Pharma Q1 EPS $(0.34) Beats $(0.48) Estimate, Sales $2.98M Beat $1.58M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
NewAmsterdam Pharma (NASDAQ:NAMS) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.48) by 29.17 percent. The company reported quarterly sales of $2.98 million which beat
NewAmsterdam Pharma (NASDAQ:NAMS) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.48) by 29.17 percent. The company reported quarterly sales of $2.98 million which beat the analyst consensus estimate of $1.58 million by 89.01 percent. This is a 112.56 percent increase over sales of $1.40 million the same period last year.